NCT02172885View on ClinicalTrials.gov

Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Osteogenesis Imperfecta
Interventions
BIOLOGICAL

Mesenchymal Stem Cells

Mesenchymal Stem Cell Infusions

Trial Locations (2)

48903

Hospital Universitario Cruces, Barakaldo

Unknown

Hospital Universitario Getafe, Getafe

All Listed Sponsors
collaborator

Hospital Universitario Getafe

OTHER

collaborator

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

OTHER

lead

Hospital de Cruces

OTHER

NCT02172885 - Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta | Biotech Hunter | Biotech Hunter